fda glp-1 compounding crackdown september 2025 National Hispanic Medical Association | The federal government is stepping up to stop counterfeit weight-loss drugs. In 2025, bipartisan lawmakers urged stronger enforcement September 2, 2025: U.S. compounding

They are generally not recommended for patients with a personal or family history of medullary thyroid cancer or Multiple Endocrine Neoplasia syndrome type 2 (MEN2), those who are pregnant or breastfeeding or planning pregnancy, patients with a known allergy to the medication, severe gastroparesis or serious digestive motility disorders, active pancreatitis or significant pancreatitis history, serious gallbladder disease, certain kidney conditions, or active eating disorder concerns

You can read more about B12 here

One drink four hours prior still creates moderate somatostatin elevation, reducing GH response by 3050%

Within a few more minutes it was down to 50/30

It is a synthetic analog of growth hormone-releasing hormone (GHRH), designed to stimulate specific biological mechanisms involved in hormone signaling and metabolic regulation